Newman Dignan & Sheerar, Inc. Johnson & Johnson Transaction History

Newman Dignan & Sheerar, Inc.

$585 Million
Q3 2024

A detailed history of Newman Dignan & Sheerar, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 24,422 shares of JNJ stock, worth $3.77 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

24,422

Previous 24,409 0.05%

Holding current value

$3.77 Million

Previous $3.57 Million 10.93%

% of portfolio

0.68%

Previous 0.92%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $1,891 - $2,175	13 Added 0.05%	24,422 $3.96 Million
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $31,763 - $34,711	-220 Reduced 0.89%	24,409 $3.57 Million
Q1 2024 Apr 26, 2024	SELL	$155.22 - $162.74 $158,324 - $165,994	-1,020 Reduced 3.98%	24,629 $3.9 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $56,784 - $61,963	390 Added 1.54%	25,649 $4.02 Million
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $151,077 - $169,245	-970 Reduced 3.7%	25,259 $3.93 Million
Q2 2023 Aug 02, 2023	SELL	$154.35 - $166.11 $32,876 - $35,381	-213 Reduced 0.81%	26,229 $4.34 Million
Q1 2023 Apr 28, 2023	SELL	$151.05 - $180.26 $434,117 - $518,067	-2,874 Reduced 9.8%	26,442 $4.1 Million
Q4 2022 Jan 20, 2023	SELL	$160.2 - $179.79 $4,325 - $4,854	-27 Reduced 0.09%	29,316 $0
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $10,647 - $11,848	66 Added 0.23%	29,343 $4.79 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $61,893 - $68,451	-368 Reduced 1.24%	29,277 $5.2 Million
Q1 2022 Apr 14, 2022	SELL	$158.14 - $179.59 $1,106 - $1,257	-7 Reduced 0.02%	29,645 $5.25 Million
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $61,280 - $67,992	-393 Reduced 1.31%	29,652 $5.07 Million
Q3 2021 Oct 07, 2021	BUY	$161.5 - $179.47 $14,696 - $16,331	91 Added 0.3%	30,045 $4.85 Million
Q2 2021 Jul 28, 2021	SELL	$159.48 - $171.07 $16,426 - $17,620	-103 Reduced 0.34%	29,954 $4.94 Million
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $32,297 - $35,971	211 Added 0.71%	30,057 $4.94 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $88,435 - $101,510	-645 Reduced 2.12%	29,846 $4.7 Million
Q3 2020 Oct 14, 2020	BUY	$140.38 - $153.83 $8,001 - $8,768	57 Added 0.19%	30,491 $4.54 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $35.6 Million - $43 Million	-276,590 Reduced 90.09%	30,434 $4.47 Million
Q1 2020 Apr 20, 2020	BUY	$111.14 - $153.99 $30.6 Million - $42.4 Million	275,434 Added 871.9%	307,024 $4.53 Million
Q4 2019 Jan 15, 2020	SELL	$127.5 - $146.44 $74,460 - $85,520	-584 Reduced 1.82%	31,590 $4.61 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $132,916 - $148,820	-1,047 Reduced 3.15%	32,174 $4.16 Million
Q2 2019 Jul 31, 2019	SELL	$131.15 - $144.24 $25,967 - $28,559	-198 Reduced 0.59%	33,221 $4.63 Million
Q1 2019 Apr 09, 2019	SELL	$125.72 - $139.79 $239,873 - $266,719	-1,908 Reduced 5.4%	33,419 $4.67 Million
Q4 2018 Jan 24, 2019	BUY	$122.84 - $147.84 $19,900 - $23,950	162 Added 0.46%	35,327 $4.56 Million
Q3 2018 Oct 25, 2018	BUY	$121.58 - $142.88 $48,388 - $56,866	398 Added 1.14%	35,165 $4.89 Million
Q2 2018 Jul 06, 2018	BUY	$119.4 - $131.76 $10,387 - $11,463	87 Added 0.25%	34,767 $4.22 Million
Q1 2018 Apr 17, 2018	SELL	$125.1 - $148.14 $82,816 - $98,068	-662 Reduced 1.87%	34,680 $4.53 Million
Q4 2017 Jan 29, 2018	SELL	$131.22 - $143.62 $102,876 - $112,598	-784 Reduced 2.17%	35,342 $4.94 Million
Q3 2017 Oct 18, 2017	SELL	$129.47 - $135.38 $46,479 - $48,601	-359 Reduced 0.98%	36,126 $4.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	36,485	36,485 $4.83 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Account

Newman Dignan & Sheerar, Inc. Johnson & Johnson Transaction History